Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?

Current Cancer Drug Targets
A P AlvesC J Maia

Abstract

Hepatocellular carcinoma (HCC) is the most frequently detected primary malignant liver tumor, representing a worldwide public health problem due to its high morbidity and mortality rates. The HCC is commonly detected in advanced stage, precluding the use of treatments with curative intent. For this reason, it is crucial to find effective therapies for HCC. Cancer cells have a high dependence of glycolysis for ATP production, especially under hypoxic environment. Such dependence provides a reliable possible strategy to specifically target cancer cells based on the inhibition of glycolysis. HCC, such as other cancer types, presents a clinically well-known upregulation of several glycolytic key enzymes and proteins, including glucose transporters particularly glucose transporter 1 (GLUT1). Such enzymes and proteins constitute potential targets for therapy. Indeed, for some of these targets, several inhibitors were already reported, such as 2-Deoxyglucose, Imatinib or Flavonoids. Although the inhibition of glycolysis presents a great potential for an anticancer therapy, the development of glycolytic inhibitors as a new class of anticancer agents needs to be more explored. Herein, we propose to summarize, discuss and present an over...Continue Reading

References

Aug 1, 1992·Mutation Research·T MoritaK Okumura
May 1, 1990·Archives of Biochemistry and Biophysics·Y H Ko, B A McFadden
Mar 31, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·T KannoK Fukutake
Feb 1, 1986·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·P L Lantos
Nov 1, 1985·Experimental Cell Research·A CattaneoP Calissano
Oct 1, 1965·Proceedings of the National Academy of Sciences of the United States of America·H M Katzen, R T Schimke
Jan 1, 1995·Reviews of Physiology, Biochemistry and Pharmacology·J E Wilson
Apr 16, 1998·Biochimica Et Biophysica Acta·M L CárdenasT Ureta
Aug 6, 1998·Cytogenetics and Cell Genetics·P S WhiteG M Brodeur
Oct 10, 1998·International Journal of Cancer. Journal International Du Cancer·L OrlandiR Silvestrini
Oct 31, 1998·Current Opinion in Genetics & Development·G L Semenza
Jun 9, 1999·International Journal of Cancer. Journal International Du Cancer·A BiroccioA Floridi
Jul 15, 1999·Biochemical and Biophysical Research Communications·J B Park
Aug 31, 1999·Brain Research Bulletin·B FélixJ P Laplace
Feb 26, 2000·Carcinogenesis·J Yokota
Jun 8, 2000·The Journal of Clinical Endocrinology and Metabolism·O OguehM R Johnson
Dec 29, 2000·Seminars in Surgical Oncology·P J Johnson
May 2, 2001·Biochemistry·H LiuT J Lampidis
May 10, 2001·Mutation Research·J S PentaW C Copeland
Aug 8, 2001·European Journal of Biochemistry·B Comín-AnduixM Cascante
Aug 28, 2001·Gastroenterology·A E Reid
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ju-Seog Lee, Snorri S Thorgeirsson
May 23, 2002·Gastroenterology·Alex S Befeler, Adrian M Di Bisceglie
May 29, 2002·Biochimica Et Biophysica Acta·Christopher P CorpeCharles F Burant
Oct 31, 2002·The Journal of Biological Chemistry·Bernard L Horecker
Jan 7, 2003·Molecular Cancer·Jennifer S Carew, Peng Huang
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Feb 6, 2003·The British Journal of Nutrition·I Stuart Wood, Paul Trayhurn

❮ Previous
Next ❯

Citations

Aug 15, 2018·Journal of Clinical Medicine·Meng-Yu WuChia-Jung Li
Oct 18, 2020·Journal of Personalized Medicine·Monika GjorgjievaMichelangelo Foti
Feb 8, 2021·Biochimica Et Biophysica Acta. Bioenergetics·Andrey V KuznetsovMichael J Ausserlechner
Jun 19, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yan LiuZhichao Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

Molecular Cancer
Shanmugasundaram Ganapathy-Kanniappan, Jean-Francois Geschwind
Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Zhe-Yu HuYa Cao
© 2022 Meta ULC. All rights reserved